PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Gene linked to common intellectual disability

2013-11-14
(Press-News.org) Contact information: Cheryl Shoubridge
cheryl.shoubridge@adelaide.edu.au
61-881-618-105
University of Adelaide
Gene linked to common intellectual disability University of Adelaide researchers have taken a step forward in unravelling the causes of a commonly inherited intellectual disability, finding that a genetic mutation leads to a reduction in certain proteins in the brain.

ARX is among the top four types of intellectual disability linked to the X-chromosome in males. So far, 115 families, including many large Australian families, have been discovered to carry an ARX (Aristaless related homeobox) mutation that gives rise to intellectual disability.

"There is considerable variation in the disability across families, and within families with a single mutation. Symptoms among males always include intellectual disability, as well as a range of movement disorders of the hand, and in some cases severe seizures," says Associate Professor Cheryl Shoubridge, Head of Molecular Neurogenetics with the University of Adelaide's Robinson Institute.

ARX mutations were first discovered by the University of Adelaide's Professor Jozef Gecz in 2002. To date, researchers have detected 52 different ARX mutations and 10 distinct clinical syndromes.

Associate Professor Shoubridge is lead author of a new paper on ARX intellectual disability published in the journal Human Molecular Genetics.

In laboratory studies, Associate Professor Shoubridge's team has shown that mutations lead to a significant reduction in ARX proteins in the brain, but the actual causes and mechanisms involved in this remain unknown. Her team tested six genes that the ARX protein interacts with, and found that one of them – a gene likely to be important to early brain development – appears to be adversely affected by the reduction of ARX proteins.

"This plays an important role in setting up architecture and networks in the brain, which become disrupted due to the mutation," Associate Professor Shoubridge says.

"The discovery of this genetic link is an important step forward but there is still much work to be done. We're now looking further at the mechanism of the reduction in ARX protein and what that means for the brain at a functional level."

Associate Professor Shoubridge says up to 3% of the population is affected by some kind of intellectual disability, costing $14.7 billion each year in Australia alone.

"The personal cost to families is enormous, especially in the most severe cases. Being able to unravel why and how these disabilities occur is very important to us and to the many people whose lives are affected by these conditions," she says.

### This research has been funded by the Australian Research Council (ARC) and the National Health and Medical Research Council (NHMRC).

Media contact:

Associate Professor Cheryl Shoubridge
Head, Molecular Neurogenetics
Robinson Institute
The University of Adelaide
Phone: +61 8 8161 8105
cheryl.shoubridge@adelaide.edu.au


ELSE PRESS RELEASES FROM THIS DATE:

Fossil of new big cat species discovered; oldest ever found

2013-11-14
Fossil of new big cat species discovered; oldest ever found 4-million-year-old skull of relative of snow leopard fleshes out fossil record of big cats and challenges suppositions about how and where they evolved The oldest big cat fossil ever found – ...

Rapid testing to diagnose influenza leads to more appropriate care in the ED

2013-11-14
Rapid testing to diagnose influenza leads to more appropriate care in the ED When patients in the emergency department (ED) are diagnosed with influenza by means of a rapid test, they get fewer unnecessary antibiotics, are prescribed antiviral ...

Molecule common in some cancers, rheumatoid arthritis leads to potential therapy for both

2013-11-14
Molecule common in some cancers, rheumatoid arthritis leads to potential therapy for both WASHINGTON — A molecule that helps cells stick together is significantly over-produced in two very different diseases — rheumatoid arthritis and a variety of cancers, including ...

Primary care key to management of patients with HIV infection

2013-11-14
Primary care key to management of patients with HIV infection Updated HIVMA Guidelines indicate doctors should focus on common health conditions [EMBARGOED FOR NOV. 14, 2013, ARLINGTON, Va.] – The HIV Medicine Association (HIVMA) of the Infectious Diseases ...

Accidental discovery dramatically improves electrical conductivity

2013-11-14
Accidental discovery dramatically improves electrical conductivity Crystal could improve performance of electronic devices PULLMAN, Wash.—Quite by accident, Washington State University researchers have achieved a 400-fold increase in the electrical conductivity ...

Using airport screening technology to visualize waves in fusion plasma

2013-11-13
Using airport screening technology to visualize waves in fusion plasma Millimeter-wave imaging helps scientists better understand and manage plasma instabilities Millimeter-wave imaging technology is widely used in airborne radar, automotive sensors and full-body ...

New links between social status and brain activity

2013-11-13
New links between social status and brain activity Social stability affects the production of new brain cells; ability of brain to adapt is key to coping with hierarchies and stress SAN DIEGO — New studies released today reveal links between social status and specific ...

Can the eyes help diagnose Alzheimer's disease?

2013-11-13
Can the eyes help diagnose Alzheimer's disease? VIDEO: Scott Turner, M.D., Ph.D., discusses research to be presented at the Neuroscience 2013 meeting. He and an ...

Breathalyzer technology detects acetone levels to monitor blood glucose in diabetics

2013-11-13
Breathalyzer technology detects acetone levels to monitor blood glucose in diabetics Groundbreaking research to be featured at 2013 AAPS Annual Meeting and Exposition Arlington, Va. — A novel hand-held, noninvasive monitoring device that uses ...

New compound inhibits cognitive impairment in animal models of Alzheimer's disease

2013-11-13
New compound inhibits cognitive impairment in animal models of Alzheimer's disease Promising research to be featured at 2013 AAPS Annual Meeting and Exposition Arlington, Va. — The novel compound IRL-1620 may be useful in treating Alzheimer's ...

LAST 30 PRESS RELEASES:

Male bonobos track females’ reproductive cycle to maximize mating success

New report outlines science priorities for human Mars exploration

Want to curb cannabis-related crashes? Don’t forget older adults, study finds

Expectant management vs medication for patent ductus arteriosus in preterm infants

Pew funds 7 new biomedical research collaborations

The ERC selects 349 mid-career researchers for €728 million in Consolidator Grants

ERC Consolidator Grant awarded to CISPA researcher Rayna Dimitrova

Antimicrobial effects of Syzygium aromaticum and Salvadora persica against common peri-implantitis pathogens in vitro

EVs pose no greater risk to pedestrians than conventional vehicles

Modeling microplastic accumulation under the ocean surface

Pompeii offers insights into ancient Roman building technology

University of Utah engineers give a bionic hand a mind of its own

Transient and long-term risks of common physical activities in people with low back pain

Health care contact days in older adults with metastatic cancer

Brain resilience science reshapes psychiatry from treating illness to building strength

An assessment of the antidepressant potential of deramciclane in two animal tests

Pitt and UPMC study finds epigenetic signature of pediatric traumatic brain injury, paves way for precision recovery tools

Brain discovery opens door to earlier detection of metabolic syndrome in women

SwRI-led study provides insight into oscillations in solar flares

Announcing the third cohort of the Hevolution/AFAR new investigator awards in aging biology and geroscience research

GeoFlame VISION: Using AI and satellite imagery to predict future wildfire risk

Nationwide study suggests that water treatment methods may impact the risk of legionnaires’ disease

Oyster larvae on drugs move slowly and are stressed

Targeting a specific brain circuit may help prevent opioid relapse, WSU study finds

Tec-Dara combination offers substantial improvement over standard second-line therapies for relapsed or refractory multiple myeloma

Improving treatment for an autoimmune bleeding condition

Drug reduced need for blood transfusions during hospitalization for non-cardiac surgery

Novel agent ianalumab added to standard therapy extends time to treatment failure in patients with previously treated immune thrombocytopenia

Pirtobrutinib outperforms bendamustine plus rituximab for previously untreated CLL/SLL

Online tracking and privacy on hospital websites

[Press-News.org] Gene linked to common intellectual disability